Precipio Diagnostics Bringing Cutting Edge Cancer Research to Patient Treatment New Haven Start-up in Personalized Medicine Connects Yale Researchers, Oncologists

(3/13/2012) A start-up company in New Haven has established a groundbreaking collaboration with the Yale School of Medicine to bring the latest diagnostic advances in cancer research from the Yale laboratories to the hands of oncologists to treat cancer patients.

Precipio Diagnostics is in the vanguard of the personalized medicine revolution, bringing scientific breakthroughs to the broader market where the diagnostic developments can reach more oncology practices, and through them, help provide the best care to more cancer patients.
Document Download